NCDActive
FDG PET for Refractory Seizures
NCD294
Effective: January 28, 2005
Updated: December 31, 2025
Policy Summary
Medicare covers FDG-PET to localize the focus of refractory seizure activity only when performed as part of a pre-surgical evaluation. Documentation that the patient meets these pre-surgical criteria must be maintained in the referring physician's medical record. FDG-PET for refractory seizures is not covered for non–pre-surgical or other purposes.
Coverage Criteria Preview
Key requirements from the full policy
"FDG-PET is covered when performed for pre-surgical evaluation to localize a focus of refractory seizure activity."
Sign up to see full coverage criteria, indications, and limitations.